AbbVie Terminates Alzheimer’s Pact with Voyager TherapeuticsAgreements, Alzheimer’s disease, Antibodies, Business, Collaborations, Partnerships, Premarket Trading, Shares, Terminations, Vectorized AntibodiesTwo years after AbbVie and Voyager Therapeutics first forged a collaboration to develop treatments for Alzheimer’s disease, the partnership came to an end after AbbVie terminated the agreement. Read more August 4, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/08/AbbVie-Terminates-Alzheimers-Pact-with-Voyager-Therapeutics-BioSpace-8-4-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-08-04 12:17:162020-08-04 14:06:13AbbVie Terminates Alzheimer’s Pact with Voyager Therapeutics